ProQR to Present at Upcoming Scientific Conferences Press release LEIDEN, Netherlands and CAMBRIDGE, Mass., Nov. November 18, 2019
ProQR Announces Virtual Presentations at Scientific Conferences Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. September 24, 2020
ProQR to Present at Three Scientific Conferences in April Press release LEIDEN, Netherlands and CAMBRIDGE, Mass., April 22, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. April 22, 2019
ProQR Receives Orphan Drug Designation from FDA for Drug Candidate QR-313 for Dystrophic Epidermolysis Bullosa and will Present Data at two Scientific Conferences Press release Key Updates September 19, 2017
ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-010 for Cystic Fibrosis at Two Upcoming Scientific Conferences Press release LEIDEN, Netherlands, Oct. 1, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. October 01, 2015
ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. October 07, 2024
ProQR Announces Results for the Fourth Quarter and Full Year 2017 and Provides Business Update Press release … and presented positive pre-clinical data at two European scientific conferences. WINGS, a Phase 1/2 safety and … F508del mutation were presented at the North American CF conference. A Phase 2 study is currently being designed and … February 28, 2018
ProQR to Present at Scientific and Investor Conferences in September Press release LEIDEN, the Netherlands, Sept. 06, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. September 06, 2016
ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event Press release … over the next 12 months, including liver NHP data, at scientific conferences, as well as research related to … March 29, 2023
ProQR Announces Financial Results for the First Quarter of 2019 Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. May 08, 2019
